{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:41:34Z","timestamp":1785552094146,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":671,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.micinf.2021.104884","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T11:32:50Z","timestamp":1630668770000},"page":"104884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis"],"prefix":"10.1016","volume":"24","author":[{"given":"Daniel Claudio Oliveira","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Lilian da Silva Costa","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Porto","family":"Schwedersky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Polaco","family":"Covre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Leonel","family":"de Matos Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulisses Gazos","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas","family":"R\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartira","family":"Rossi-Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2021.104884_bib1","series-title":"OMS | leishmaniasis","first-page":"375","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.micinf.2021.104884_bib2","article-title":"Leishmaniasis and various immunotherapeutic approaches","volume":"1\u201311","author":"Taslimi","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.micinf.2021.104884_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2010.06.024","article-title":"Leishmaniasis vaccines: past, present and future","volume":"36","author":"Modabber","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.micinf.2021.104884_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2174\/138945008786786091","article-title":"Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics","volume":"9","author":"Kumari","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.micinf.2021.104884_bib5","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin & Trans Immunol"},{"key":"10.1016\/j.micinf.2021.104884_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","article-title":"New insights in mucosal vaccine development","volume":"30","author":"Pavot","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2021.104884_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-3024.2003.00632.x","article-title":"The mucosal immune system","volume":"25","author":"Macdonald","year":"2003","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.micinf.2021.104884_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2017.0022","article-title":"Intranasal administration of whole inactivated influenza virus vaccine as a promising influenza vaccine candidate","volume":"30","author":"Ainai","year":"2017","journal-title":"Viral Immunol"},{"key":"10.1016\/j.micinf.2021.104884_bib9","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1128\/IAI.00263-13","article-title":"Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin","volume":"81","author":"Carapau","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2021.104884_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/CVI.00477-10","article-title":"Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue","volume":"18","author":"Fernandez","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micinf.2021.104884_bib11","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.vaccine.2016.04.018","article-title":"Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis","volume":"34","author":"Stegmiller","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2021.104884_bib12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1017\/S0031182012000868","article-title":"Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis","volume":"139","author":"de Oliveira Gomes","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.micinf.2021.104884_bib13","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA- and protein-based vaccines against leishmania major evaluated using low-dose, intradermal challenge","volume":"166","author":"M\u00e9ndez","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2021.104884_bib14","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1017\/S0031182011001417","article-title":"Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi","volume":"138","author":"de Oliveira Gomes","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.micinf.2021.104884_bib15","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","article-title":"Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK","volume":"72","author":"Pinto","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2021.104884_bib16","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.vaccine.2006.11.060","article-title":"Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice","volume":"25","author":"Gomes","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2021.104884_bib17","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1016\/j.vaccine.2015.07.101","article-title":"Chitosan-based mucosal adjuvants: sunrise on the ocean","volume":"33","author":"Xia","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2021.104884_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4161\/hv.27449","article-title":"Chitosan a promising safe and immune-enhancing adjuvant for intranasal vaccines","volume":"10","author":"Smith","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.micinf.2021.104884_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/17425247.2016.1121989","article-title":"Sizing the optimal dimensions of a vaccine delivery system: a particulate matter","volume":"13","author":"Sl\u00fctter","year":"2016","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.micinf.2021.104884_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/acs.molpharmaceut.6b00434","article-title":"Adjuvanticity regulation by biodegradable polymeric nano\/microparticle size","volume":"14","author":"Jia","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.micinf.2021.104884_bib21","first-page":"693","article-title":"DNA \u2013 chitosan nanoparticles improve DNA vaccine-elicited immunity against Newcastle disease virus through shuttling chicken interleukin-2","volume":"27","author":"Zhang","year":"2010","journal-title":"Gene"},{"key":"10.1016\/j.micinf.2021.104884_bib22","series-title":"Chitosan for gene, DNA vaccines, and drug delivery","author":"Rodrigues","year":"2019"},{"key":"10.1016\/j.micinf.2021.104884_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/CVI.00263-10","article-title":"Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen A protects mice against nasopharyngeal colonization by Streptococcus pneumoniae","volume":"18","author":"Xu","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micinf.2021.104884_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2014.07.005","article-title":"Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes","volume":"473","author":"Sawaengsak","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.micinf.2021.104884_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/1061186X.2012.662686","article-title":"Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen","volume":"20","author":"Bhowmik","year":"2012","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.micinf.2021.104884_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.actatropica.2013.07.011","article-title":"A\u00a0novel chitosan based antimalarial drug delivery against Plasmodium berghei infection","volume":"128","author":"Tripathy","year":"2013","journal-title":"Acta Trop"},{"key":"10.1016\/j.micinf.2021.104884_bib27","volume":"vol. 19","author":"Seferian","year":"2001"},{"key":"10.1016\/j.micinf.2021.104884_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/md18120605","article-title":"The application of mucoadhesive chitosan nanoparticles in nasal drug delivery","volume":"18","author":"Shim","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.micinf.2021.104884_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2012.04.012","article-title":"Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study","volume":"430","author":"Vllasaliu","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.micinf.2021.104884_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2009.07.028","article-title":"Ionically crosslinked chitosan\/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery","volume":"382","author":"Csaba","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.micinf.2021.104884_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00163","article-title":"Chitosan microsphere used as an effective system to deliver a linked antigenic peptides vaccine protect mice against acute and chronic Toxoplasmosis","volume":"8","author":"Guo","year":"2018","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.1016\/j.micinf.2021.104884_bib32","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.micinf.2021.104884_bib33","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1002\/eji.201242372","article-title":"The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses","volume":"42","author":"Mori","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2021.104884_bib34","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Ferraz Coelho","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2021.104884_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1074-7613(00)80342-8","article-title":"IL-4 Rapidly produced by V??4 V??8 CD4+ T cells instructs Th2 development and susceptibility to leishmania major in BALB\/c mice","volume":"6","author":"Launois","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.micinf.2021.104884_bib36","article-title":"IL-4 rapidly produced by V4 V8 CD4 T","volume":"vol. 6","author":"Launois","year":"1997"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457921001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457921001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:39:35Z","timestamp":1761143975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457921001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1286457921001064"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2021.104884","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2021.104884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104884"}}